Labat plans capital raise for medical cannabis business

  • Labat’s shares are trading at 39c, with a market capitalisation of R152m.
  • The company said it was in talks with high-profile investors, particularly in the US and the UK, without mentioning who those investors were.
  • Van Rooyen said they were exploring new opportunities around the world.
  • Like us, they are thinking ahead and positioning to take advantage of the opportunities that will open up when our economies are reopened, and there are encouraging signs this may happen soon, said Van Rooyen.

Read full article: